Enhancing Benefit Assessments: Insights from IQ...

By João L. Carapinha

August 11, 2025

How will the IQWiG real-world data report (linked below) change drug benefit assessments in Germany? The new IQWiG real‑world data report sets a formal framework for how real-world data (RWD) supports non-randomized comparative studies underpin...
Building a Better Ecosystem for Digitally Enabled Diabetes Care in Europe
NICE HealthTech Methods Update
Elderly Care Costs 2025: Rising Financial Pressures in Dutch Health Services
Federated Learning Governance in Healthcare: A Framework for Ethical and Effe...
AI Clinician in Pediatric ICU: A Review and HEOR Perspective
Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical ...
The Value of Self-Care in Public Health: Insights and Implications for Europe
Mavyret Acute Hepatitis C: Pioneering Treatment Expansion and Economic Implic...
EHK Clusters 2026 Report: Enhancements in Dutch Risk Equalization for High-Co...
Revitalizing Innovation: The Impact of UK Medicine Payment Rates
Pluvicto Prostate Cancer Trial: Phase III Results
Business Dynamics: How Novo Nordisk Lost GLP-1 Market Share